Allergan plc (NYSE: AGN) investors have enjoyed seeing the stock price increase by 16.9% over the last month. As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let’s take a look at the company’s expected growth and valuation based on its most recent financial data to see if there is further upside moving forward.

What Is Allergan Worth?

According to our 5 valuation models, Allergan seems to be fairly priced in the market at 2.4% below its intrinsic value. This means if you were to buy Allergan today, you’d be paying a reasonable price for it. If you believe that the stock is really worth $166.15, then there isn’t much room for the share price to appreciate beyond where it’s currently trading.

Allergan plc Valuation Detail Analysis Model Fair Value Upside (Downside) 10-yr DCF Revenue Exit $252.03 55.3% 5-yr DCF Revenue Exit $207.85 28.1% Peer Revenue Multiples $135.96 -16.2% Peer EBITDA Multiples $123.11 -24.1% Dividend Discount Model (multi-stage) $111.78 -31.1% Average $166.15 2.4%

^{Click on any of the analyses above to view the latest model with real-time data.}

Although, there may be an opportunity to buy in the future. This is because Allergan’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

How Much Growth Will Allergan Generate?

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations.